Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation
Tài liệu tham khảo
Schachter, 2000, The joys of HexNAc. The synthesis and function of N- and O-glycan branches, Glycoconj. J., 17, 465, 10.1023/A:1011010206774
Helenius, 2001, Intracellular functions of N-linked glycans, Science, 291, 2364, 10.1126/science.291.5512.2364
Kornfeld, 1985, Assembly of asparagine-linked oligosaccharides, Annu. Rev. Biochem., 54, 631, 10.1146/annurev.bi.54.070185.003215
Ohtsubo, 2006, Glycosylation in cellular mechanisms of health and disease, Cell, 126, 855, 10.1016/j.cell.2006.08.019
Dennis, 2009, Metabolism, cell surface organization, and disease, Cell, 139, 1229, 10.1016/j.cell.2009.12.008
Brisson, 1983, Solution conformation of asparagine-linked oligosaccharides: alpha(1-2)-, alpha(1-3)-, beta(1-2)-, and beta(1-4)-linked units, Biochemistry, 22, 3671, 10.1021/bi00284a021
André, 2004, Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo, Eur. J. Biochem., 271, 118, 10.1046/j.1432-1033.2003.03910.x
Ihara, 1993, cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III), J. Biochem., 113, 692, 10.1093/oxfordjournals.jbchem.a124105
Cummings, 1982, A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc: alpha-d-mannoside beta 1,6 N-acetylglucosaminyltransferase, J. Biol. Chem., 257, 13421, 10.1016/S0021-9258(18)33465-3
Ujita, 1999, Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of I-extension enzyme and beta1,4-galactosyltransferase I, J. Biol. Chem., 274, 16717, 10.1074/jbc.274.24.16717
van den Eijnden, 1988, Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc:N-acetyllactosaminide beta 1–3-N-acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid, J. Biol. Chem., 263, 12461, 10.1016/S0021-9258(18)37777-9
Hirabayashi, 2002, Oligosaccharide specificity of galectins: a search by frontal affinity chromatography, Biochim. Biophys. Acta, 1572, 232, 10.1016/S0304-4165(02)00311-2
Partridge, 2004, Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis, Science, 306, 120, 10.1126/science.1102109
Saito, 1994, cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+, Biochem. Biophys. Res. Commun., 198, 318, 10.1006/bbrc.1994.1045
Kang, 1996, Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1, J. Biol. Chem., 271, 26706, 10.1074/jbc.271.43.26706
Ko, 1999, Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines, J. Biol. Chem., 274, 22941, 10.1074/jbc.274.33.22941
Buckhaults, 1997, Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene, J. Biol. Chem., 272, 19575, 10.1074/jbc.272.31.19575
Chen, 1998, The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products, Oncogene, 17, 2087, 10.1038/sj.onc.1202124
Fernandes, 1991, Beta 1–6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia, Cancer Res., 51, 718
Seelentag, 1998, Prognostic value of beta1,6-branched oligosaccharides in human colorectal carcinoma, Cancer Res., 58, 5559
Granovsky, 2000, Suppression of tumor growth and metastasis in Mgat-5 deficient mice, Nature, 6, 306
Dosaka-Akita, 2004, Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers, Clin. Cancer Res., 10, 1773, 10.1158/1078-0432.CCR-1047-3
Inamori, 2006, High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis, FEBS Lett., 580, 627, 10.1016/j.febslet.2005.12.089
Rebbaa, 1999, Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine, Clin. Cancer Res., 5, 3661
Yoshimura, 1996, Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization, Cancer Res., 56, 412
Song, 2010, The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression, Cancer Res., 70, 3361, 10.1158/0008-5472.CAN-09-2719
Sheng, 1997, Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing beta1,4-N-acetylglucosaminyltransferase III, Int. J. Cancer, 73, 850, 10.1002/(SICI)1097-0215(19971210)73:6<850::AID-IJC15>3.0.CO;2-8
Yoshimura, 1995, Supression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection, Proc. Natl. Acad. Sci. U.S.A., 92, 8754, 10.1073/pnas.92.19.8754
Przybyło, 2007, Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis, Biochim. Biophys. Acta, 1770, 1427, 10.1016/j.bbagen.2007.05.006
Ciołczyk-Wierzbicka, 2004, The structure of the oligosaccharides of N-cadherin from human melanoma cell lines, Glycoconj. J., 20, 483, 10.1023/B:GLYC.0000038294.72088.b0
Kremser, 2008, Characterisation of alpha3beta1 and alpha(v)beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines, Biochim. Biophys. Acta, 1780, 1421, 10.1016/j.bbagen.2008.07.011
Hoja-Łukowicz, 2013, L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells, Glycoconj. J., 30, 205, 10.1007/s10719-012-9374-5
Zhao, 2006, N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration, J. Biol. Chem., 281, 32122, 10.1074/jbc.M607274200
Guo, 2007, Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase, J. Biol. Chem., 282, 22150, 10.1074/jbc.M611518200
Campbell, 2008, CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells, J. Biol. Chem., 283, 30745, 10.1074/jbc.M804112200
Peterson, 1977, A simplification of the protein assay method of Lowry et al. which is more generally applicable, Anal. Biochem., 83, 346, 10.1016/0003-2697(77)90043-4
Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0
Towbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. U.S.A., 76, 4350, 10.1073/pnas.76.9.4350
Ochwat, 2004, N-glycoproteins bearing β-1,6 branched oligosaccharides from A375 human melanoma cell line analysed by tandem mass spectrometry, Melanoma Res., 14, 479, 10.1097/00008390-200412000-00007
Haselbeck, 1990, Structural characterization of glycoprotein carbohydrate chains by using digoxigenin-labeled lectins on blots, Anal. Biochem., 191, 25, 10.1016/0003-2697(90)90381-I
Taniguchi, 1989, Glycosyltransferase assays using pyridylaminated acceptors: N-acetylglucosaminyltransferase III, IV, and V, Methods Enzymol., 179, 397, 10.1016/0076-6879(89)79139-4
Packer, 1998, A general approach to desalting oligosaccharides released from glycoproteins, Glycoconj. J., 15, 737, 10.1023/A:1006983125913
Bigge, 1995, Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid, Anal. Biochem, 230, 229, 10.1006/abio.1995.1468
Neville, 2004, Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling, Anal. Biochem., 331, 275, 10.1016/j.ab.2004.03.051
Seales, 2003, Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin, Oncogene, 22, 7137, 10.1038/sj.onc.1206834
Kamar, 2004, Analysis of the site-specific N-glycosylation of beta1,6 N-acetylglucosaminyltransferase V, Glycobiology, 14, 583, 10.1093/glycob/cwh062
Nagai, 1997, N-glycosylation is requisite for the enzyme activity and Golgi retention of N-acetylglucosaminyltransferase III, Glycobiology, 7, 769, 10.1093/glycob/7.6.769
Sasai, 2003, Caveolin-1 regulates the functional localization of N- acetylglucosaminyltransferase III within the golgi apparatus, J. Biol. Chem., 278, 25295, 10.1074/jbc.M301913200
Cummings, 1982, Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins, J. Biol. Chem., 57, 11230, 10.1016/S0021-9258(18)33746-3
Ono, 2004, Glycosylation defining cancer cell motility and invasiveness, Glycoconj. J., 20, 71, 10.1023/B:GLYC.0000018019.22070.7d
Gu, 2012, Potential roles of N-glycosylation in cell adhesion, Glycoconj. J., 29, 599, 10.1007/s10719-012-9386-1
Xie, 1997, Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis, Cancer Res., 57, 2295
Weinstein, 1982, Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver, J. Biol. Chem., 257, 13845, 10.1016/S0021-9258(18)33525-7
Ju, 2002, Purification, characterization, and subunit structure of rat core 1 Beta1,3-galactosyltransferase, J. Biol. Chem., 277, 169, 10.1074/jbc.M109056200
Comelli, 2006, A focused microarray approach to functional glycomics: transcriptional regulation of the glycome, Glycobiology, 16, 117, 10.1093/glycob/cwj048
Saito, 1995, Organization of the human N-acetylglucosaminyltransferase V gene, Eur. J. Biochem, 233, 18, 10.1111/j.1432-1033.1995.018_1.x
Koyama, 1996, Human N-acetylglucosaminyltransferase III gene is transcribed from multiple promoters, Eur. J. Biochem., 238, 853, 10.1111/j.1432-1033.1996.0853w.x
Chakraborty, 2006, GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription, Gene, 7, 166, 10.1016/j.gene.2006.01.031
Pinho, 2012, Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions, PLoS One, 7, e33191, 10.1371/journal.pone.0033191
Taniguchi, 2011, Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics, BMB Rep., 44, 772, 10.5483/BMBRep.2011.44.12.772
Guo, 2008, Loss of expression of N-acetylglucosaminyltransferase Va results in altered gene expression of glycosyltransferases and galectins, FEBS Lett., 582, 527, 10.1016/j.febslet.2008.01.015
Pinho, 2013, E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V, Biochim. Biophys. Acta, 1830, 2690, 10.1016/j.bbagen.2012.10.021
Koyota, 2001, Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc, J. Biol. Chem., 276, 32867, 10.1074/jbc.M102371200
Allen, 1984, Control of glycoprotein synthesis. The in vitro synthesis by hen oviduct membrane preparations of hybrid asparagine-linked oligosaccharides containing 5 mannose residues, J. Biol. Chem., 259, 6984, 10.1016/S0021-9258(17)39826-5
Brockhausen, 1988, Control of glycoprotein synthesis. The use of oligosaccharide substrates and HPLC to study the sequential pathway for N-acetylglucosaminyltransferases I, II, III, IV, V, and VI in the biosynthesis of highly branched N-glycans by hen oviduct membranes, Biochem. Cell Biol., 66, 1134, 10.1139/o88-131
Sasai, 2002, The action of N-acetylglucosaminyltransferase-V is prevented by the bisecting GlcNAc residue at the catalytic step, FEBS Lett., 522, 151, 10.1016/S0014-5793(02)02916-2
Longmore, 1982, Product-identification and substrate-specificity studies of the GDP-L-fucose:2-acetamido-2-deoxy-beta-D-glucoside (FUC goes to Asn-linked GlcNAc) 6-alpha-L-fucosyltransferase in a Golgi-rich fraction from porcine liver, Carbohydr. Res., 100, 365, 10.1016/S0008-6215(00)81049-6
North, 2010, Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity, J. Biol. Chem., 285, 5759, 10.1074/jbc.M109.068353
Inamori, 2003, Molecular cloning and characterization of human GnT-IX, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain, J. Biol. Chem., 278, 43102, 10.1074/jbc.M308255200
Kaneko, 2003, A novel beta(1,6)-N-acetylglucosaminyltransferase V (GnT-VB)(1), FEBS Lett., 554, 515, 10.1016/S0014-5793(03)01234-1
Lee, 2012, Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V, J. Biol. Chem., 287, 28526, 10.1074/jbc.M112.367565
Yoshimura, 1996, Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis, J. Biol. Chem., 271, 13811, 10.1074/jbc.271.23.13811
Chen, 2009, Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry, J. Proteome Res., 8, 651, 10.1021/pr8008012
Shih, 1994, Isolation and functional characterization of the A32 melanoma-associated antigen, Cancer Res., 54, 2514
Jouve, 2013, The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells, J. Biol. Chem., 288, 2571, 10.1074/jbc.M112.418848
Sultan, 1997, Bisecting GlcNAc structures act as negative sorting signals for cell surface glycoproteins in forskolin-treated rat hepatoma cells, J. Biol. Chem., 272, 2866, 10.1074/jbc.272.5.2866
Lehmann, 1989, MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily, Proc. Natl. Acad. Sci. U.S.A., 86, 9891, 10.1073/pnas.86.24.9891
Luo, 2012, Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration, Oncogene, 31, 306, 10.1038/onc.2011.244
Zhao, 2008, Functional roles of N-glycans in cell signaling and cell adhesion in cancer, Cancer Sci., 99, 1304, 10.1111/j.1349-7006.2008.00839.x
Seberger, 1999, Control of metastasis by Asn-linked, beta1-6 branched oligosaccharides in mouse mammary cancer cells, Glycobiology, 9, 235, 10.1093/glycob/9.3.235
Barthel, 2009, Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking, Proc. Natl. Acad. Sci. U.S.A., 106, 19491, 10.1073/pnas.0906074106
Derappe, 1996, Circulating malignant lymphocytes from Sezary syndrome express high level of glycoproteins carrying beta (1-6)N-acetylglucosamine-branched N-linked oligosaccharides, Leukemia, 10, 138
Dawson, 2004, Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death, J. Neurochem., 89, 1436, 10.1111/j.1471-4159.2004.02435.x
VanderElst, 1991, N-linked oligosaccharide processing and autocrine stimulation of tumor cell proliferation, Exp. Cell Res., 192, 612, 10.1016/0014-4827(91)90083-7
Chen, 2012, All-trans-retinoic acid modulates ICAM-1 N-glycan composition by influencing GnT-III levels and inhibits cell adhesion and trans-endothelial migration, PLoS One, 7, e52975, 10.1371/journal.pone.0052975
Takamatsu, 2010, Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice, Glycobiology, 20, 485, 10.1093/glycob/cwp200
Fuster, 2005, The sweet and sour of cancer: glycans as novel therapeutic targets, Nat. Rev. Cancer, 5, 526, 10.1038/nrc1649